CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L107. A total of 13 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $42,000 | – | 7,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bracebridge Capital, LLC | 2,002,495 | $2,984,000 | 0.22% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 90,000 | $134,000 | 0.00% |
| Virtu Financial LLC | 20,353 | $30,000 | 0.00% |
| Verition Fund Management LLC | 30,000 | $45,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 40 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 33,915 | $50,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 39,228 | $58,000 | 0.00% |
| CITIGROUP INC | 7,400 | $11,000 | 0.00% |
| Renaissance Technologies | 34,700 | $52,000 | 0.00% |